Literature DB >> 15073757

Adverse drug reaction monitoring--cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions.

N Muehlberger1, S Schneeweiss, J Hasford.   

Abstract

In an era of health care cost containment it is of particular interest to identify measures that reduce costs and at the same time improve health care quality. One of these cost cutting measures might be the reduction of the frequency of Adverse Drug Reactions (ADR). The objective of this paper is to summarize all original work on ADR frequencies at hospital admission and to come up with a valid estimate for the actual frequency of ADR-related hospital admissions. Additionally, we compared established concepts of ADR monitoring with respect to their utility for drug safety monitoring and pharmacoepidemiologic research. We reviewed 25 studies from the past 25 years. Analysing the effect of methodological characteristics showed that variation of reported ADR frequency mainly depends on differing study bases and the concepts of ADR monitoring. Investigations that thoroughly screened all members of the study population for the presence of adverse drug reactions (comprehensive ADR monitoring) generally yielded highest ADR proportions. Studies that concentrated screening on selected high-risk patients (preselective ADR monitoring) and those applying spontaneous or intensified spontaneous reporting detected lower ADR proportions (2.9% and 2.5%). The ADR proportion among admissions to departments of internal medicine was higher than among mixed hospital populations including surgical patients. In conclusion 4.2-6.0% (lower and upper quartile) and in median 5.8% of all admissions to medical departments are caused by adverse drug reactions. A two-step preselective ADR monitoring appears to be appropriate and efficient for both signal generation and signal validation as compared to spontaneous reporting and comprehensive monitoring. In conclusion, adverse drug reactions are a common cause of hospital admissions. As hospital care is expensive, attempts to prevent ADR and thus hospital admission need active encouragement. Copyright 1997 John Wiley & Sons, Ltd.

Entities:  

Year:  1997        PMID: 15073757     DOI: 10.1002/(sici)1099-1557(199710)6:3+<s71::aid-pds282>3.3.co;2-9

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  36 in total

Review 1.  Methods and systems to detect adverse drug reactions in hospitals.

Authors:  P A Thürmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  First results from an intensified monitoring system to estimate drug related hospital admissions.

Authors:  S Schneeweiss; M Göttler; J Hasford; W Swoboda; M Hippius; A K Hoffmann; A K Riethling; J Krappweis
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

3.  Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies.

Authors:  Priya Bahri
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

4.  Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.

Authors:  Maria Cristina G Passarelli; Wilson Jacob-Filho; Albert Figueras
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Adverse Drug Reactions (ADR) and Emergencies.

Authors:  A Marlen Schurig; Miriam Böhme; Katja S Just; Catharina Scholl; Harald Dormann; Bettina Plank-Kiegele; Thomas Seufferlein; Ingo Gräff; Matthias Schwab; Julia C Stingl
Journal:  Dtsch Arztebl Int       Date:  2018-04-13       Impact factor: 5.594

6.  Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?

Authors:  Ana F Macedo; Francisco B Marques; Carlos F Ribeiro
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.

Authors:  Cornelis S van der Hooft; Miriam C J M Sturkenboom; Kees van Grootheest; Herre J Kingma; Bruno H Ch Stricker
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

8.  Drug-related deaths: an analysis of the Italian spontaneous reporting database.

Authors:  Roberto Leone; Laura Sottosanti; Maria Luisa Iorio; Carmela Santuccio; Anita Conforti; Vilma Sabatini; Ugo Moretti; Mauro Venegoni
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach.

Authors:  Petra A Thuermann; Roland Windecker; Joachim Steffen; Markus Schaefer; Ute Tenter; Erich Reese; Hermann Menger; Klaus Schmitt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Factors predicting hospital readmissions related to adverse drug reactions.

Authors:  Borja Ruiz; Montserrat García; Urko Aguirre; Carmelo Aguirre
Journal:  Eur J Clin Pharmacol       Date:  2008-04-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.